Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Albers

Showing results (111-120 of 205) with videos related to

Pageof 21
Sort By:
The Journal of Urology|May 23, 1998
Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancerW Brennemann, B Stoffel-Wagner, M Wichers, et al.
Aktuelle Urologie|July 25, 2007
[Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma]K Miller, L Bergmann, P Albers, et al.
Anticancer Research|August 6, 2000
Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCRP Albers, Y Ko, E Wardelmann, et al.
World Journal of Urology|July 12, 2012
Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patientsD Barski, M Richter, C Winter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapyP Albers, J Albers, O W Cummings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gene expression profiling in seminoma and nonseminomaM Port, H U Schmelz, M Stockinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessmentI Leibovitch, R S Foster, K K Kopecky, et al.
Prostate Cancer and Prostatic Diseases|July 25, 2007
Transcriptional profiling of transurethral resection samples provides insight into molecular mechanisms of hormone refractory prostate cancerO Stoss, M Werther, D Zielinski, et al.
Der Urologe. Ausg. A|July 6, 2006
[Testicular tumor--yesterday--today--tomorrow]S Krege, C Wittekind, R Souchon, et al.
The Journal of Urology|November 7, 2001
Organ sparing surgery for malignant germ cell tumor of the testisA Heidenreich, L Weissbach, W Höltl, et al.
Pageof 21

Showing results (111-120 of 205) with videos related to

Sort By:
Pageof 21
The Journal of Urology|May 23, 1998
Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancerW Brennemann, B Stoffel-Wagner, M Wichers, et al.
Aktuelle Urologie|July 25, 2007
[Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma]K Miller, L Bergmann, P Albers, et al.
Anticancer Research|August 6, 2000
Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCRP Albers, Y Ko, E Wardelmann, et al.
World Journal of Urology|July 12, 2012
Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patientsD Barski, M Richter, C Winter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapyP Albers, J Albers, O W Cummings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gene expression profiling in seminoma and nonseminomaM Port, H U Schmelz, M Stockinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessmentI Leibovitch, R S Foster, K K Kopecky, et al.
Prostate Cancer and Prostatic Diseases|July 25, 2007
Transcriptional profiling of transurethral resection samples provides insight into molecular mechanisms of hormone refractory prostate cancerO Stoss, M Werther, D Zielinski, et al.
Der Urologe. Ausg. A|July 6, 2006
[Testicular tumor--yesterday--today--tomorrow]S Krege, C Wittekind, R Souchon, et al.
The Journal of Urology|November 7, 2001
Organ sparing surgery for malignant germ cell tumor of the testisA Heidenreich, L Weissbach, W Höltl, et al.
Pageof 21